Selectivity of omeprazole inhibition towards rat liver cytochromes P450

References

• ANDERSSON, T., ANDREN, K., CEDERBERG, C., EDVARDSSON, G., HEGGELUND, A. and LUNDBORG, P. 1990a, Effect of omeprazole and cimetidine on plasma diazepam levels. European Journal of Clinical Pharmacology, 39, 51–54.
   PubMed Web of Science ®Google Scholar
• ANDERSSON, T., CEDERBERG, D., EDVARDSSON, G., HEGGELUND, A. and LUNDBORG, P., 1990b, Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolisers of omeprazole. Clinical Pharmacology and Therapeutics, 47, 79–85.
   PubMed Web of Science ®Google Scholar
• ANDERSSON, T., 1991, Omeprazole drug interaction studies. Clinical Pharrnacokinetics 21, 195–212.
   PubMed Web of Science ®Google Scholar
• BACHMANN, K. A., SuLLINAN, T. J., JAUREGUI, L., REESE, J. H., MILLER, K. and LEVINE, L., 1993, Absence of an inhibitory effect of omeprazole and nizatidine on phenytoin disposition, a marker of CYP2C activity. British Journal of Clinical Pharmacology, 36, 380–382.
   PubMedGoogle Scholar
• BLOHME', I., Iosruom, J. P. and ANDERSSON, T., 1993, A study of interaction between omeprazole and cyclosporin in renal transplant patients. British Journal of Clinical Pharmacology, 35, 156–160.
   PubMedGoogle Scholar
• BOOBIS, A. R., KAHN, G. C., WHYTE, C., BRODIE, M. J. and DAvrEs, D. S. 1981, Biphasic O-deethylation of phenacetin and 7-ethoxycoumarin by human and rat liver microsomal fractions. Biochemical Pharmacology, 30, 2451–2456.
   PubMed Web of Science ®Google Scholar
• CHENERY, R. J., AYRTON, A., OLDHAM, H. G., NORMAN, S. J. and STANDRING, P., 1988, The interaction of omeprazole with rat liver cytochrome P450-mediated monooxygenase reactions in vitro and in vivo. Biochemical Pharmacology, 37, 1407–1414.
   PubMedGoogle Scholar
• DIAZ, D., FABRE, I., DAUJAT, M., AUBERT, B. S., BORIES, P., MICHEL, H. and MAUREL, P., 1990, Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. Gastro-enterology, 99, 737–747.
   PubMed Web of Science ®Google Scholar
• GUGLER, R. and JENSEN, J. C. 1985, Omeprazole inhibits oxidative drug metabolism. Gastroenterology, 89, 1235–1241.
   PubMed Web of Science ®Google Scholar
• HENRY, D. A., GERKENS, J. F., BRENT, P. J. and DOSEN, P. J., 1986, Omeprazole: effects on oxidative drug metabolism in the rat. Clinical and Experimental Phannacologyand Physiology, 13, 377–381.
   PubMedGoogle Scholar
• HEUMAN, D. M., GALLAGHER, E. J., BARWICK, J. L., ELSHOURBAGY, N. A. and GUZELIAN, P. S., 1982, Immunochemical evidence for induction of a common form of hepatic cytochrome P450 in rats treated with pregnenolone 16-a-carbonitrile or other steroidal or non-steroidal agents. Molecular Pharmacology, 21, 753–760.
   PubMed Web of Science ®Google Scholar
• HOFFMANN, K.-J., 1986, Identification of the main urinary metabolites of omeprazole after an oral dose to rats and dogs. Drug Metabolism and Disposition, 14, 341–348.
   PubMedGoogle Scholar
• KROMER, W., POSTIUS, S., RIEDEL, R., SEVION, W. A., HANAUER, G., BRAND, U., GONNE, S. and PARSONS, M. E., 1990, BY 1023/SK&F 96022 INN pantoprozole, a novel gastric proton pump inhibitor, potency inhibits acid secretion but lacks relevant cytochrome P450 interactions. Journal of Pharmacology and Experimental Therapeutics, 254, 129–135.
   PubMedGoogle Scholar
• LAKE, B. G. and PAINE, A. J., 1983, Induction of hepatic cytochrome P450 and drug metabolism by metyrapone in the rat: relevance to its effects in rat-liver cell culture. Xenobiotica, 13, 725–730.
   PubMed Web of Science ®Google Scholar
• LAKE, B. G., 1987, Preparation and characterization of microsomal fragments for studies in xenobiotic metabolism. In Biochemical Toxicology: A Practical Approach, edited by K. Snell and B. Mullock (Washington: (RL), pp. 204–206.
   Google Scholar
• LOWRY, O. H., ROSEBROUGH, N. J., FAR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin-phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• LU, A. Y. H., SOMOGYI, A., WEST, S., KUNTZMAN, R. and Coy, A. H., 1972, Pregnenolone- 16a-carbonitrile : a new type of inducer of drug-metabolizing enzymes. Archives of Biochemistry and Biophysics, 152 457–462.
   Google Scholar
• NEVILLE, C. F., NINOMP/A, S.-L., SHEVIADA, N., KAMATAKI, T., IMAOKA, S. and FUNAE, Y., 1993, Characterisation of specific cytochrome P450 enzymes responsible for the metabolism of diazepam in hepatic microsomes of adult male rats. Biochemical Pharmacology, 45, 59–65.
   Google Scholar
• REGÄRDH, C. G., GABRIELSSON, M., HOFFMANN, K.-J., LOFBERG, L and SKANBERG, I., 1985, Pharma-cokinetics and metabolism of omeprazole in animals and man—an overview. Scandinavian Journal of Gastroenterology, 20, 79–94.
   Google Scholar
• REILLY, P. E. B., THOMPSON, D. A., MASON, S. R. and HOOPER, W. D., 1990, Cytochrome P450IIIA enzymes in rat liver microsomes : involvement in C3- hydroxylation of diazepam and nordiazepam but not N- dealkylation of diazepam and temazepam. Molecular Pharmacology 37, 767–774.
   Google Scholar
• RENBERG, L., SEVIONSSON, R. and HOFFMANN, K.-J., 1989, Identification of two main urinary metabolites of ["C] omeprazole in humans. Drug Metabolism and Disposition, 17, 69–76.
   Google Scholar
• SCHOULER, L., DUMAS, F., COUZIGOU, P., JANVIER, G., WrNNocic, S. and SARIC, J., 1991, Omeprazole-cyclosporin interaction. American Journal of Gastroenterology, 86, 1097.
   PubMedGoogle Scholar
• SIMON, W. A., BUDINGEN, C., FAHR, S., KINDER, B. and KOSKE, M., 1991, The 1-1', IC-ATPase inhibitor pantoprazole (BY1023/SK&F96022) interacts less with cytochrome P450 than omeprazole and lansoprazole. Biochemical Pharmacology, 42, 347–355.
   PubMed Web of Science ®Google Scholar
• SUTFIN, T., BALMER, K., BOSTROM, ERIKSSON, S., HOGLUND, P. and PAULSEN, O., 1989, Stereoselective interaction of omeprazole with warfarin in healthy men. Therapeutic Drug Monitoring, 11, 176–184.
   Google Scholar
• TESTA, B. and JENNER, P., 1981, Inhibitors of cytochrome P-450s and their mechanism of action. Drug Metabolism Reviews, 12, 1–117.
   PubMed Web of Science ®Google Scholar
• THOMAS, P. E., REEK, L. M., RYAN, D. E. and LEvrN, W., 1983, Induction of two immunochemically related rat liver cytochrome P450 isozymes, cytochromes P450c and P450d, by structurally diverse xenobiotics. Journal of Biological Chemistry, 258, 4590–4598.
   PubMed Web of Science ®Google Scholar
• ZOMORODI, K., CARLILE, D. J. and HOUSTON, J. B., 1995, Kinetics of diazepam metabolism in rat hepatic microsomes and hepatocytes and their use in predicting in vivo hepatic clearance. Xenobiotica, 25, 907–916.
   PubMed Web of Science ®Google Scholar
• ZOMORODI, K. and HOUSTON, J. B., 1995, Effect of omeprazole on diazepam disposition in the rat: in vitro and in vivo studies. Pharmaceutical Research, 12, 1642–1646.
   PubMed Web of Science ®Google Scholar
• ZOMORODI, K. and HOUSTON, J. B., 1996, Diazepam-omeprazole inhibition interaction: an in vitro investigation using human liver microsomes. British Journal of Clinical Pharmacology, 42, 157–162.
   PubMed Web of Science ®Google Scholar